David Cohn, MDThe James Cancer Center
- Gynecologic Oncology
- Gynecologic Cancers
- Ovarian Cancers
- Uterine Cancers
- Minimally Invasive Surgical Procedures
- Endometrial Cancers
- Cervical Cancer
- Vaginal Cancers
- Vulvar Cancers
Make an Appointment
I am a professor in the Department of Obstetrics and Gynecology and director of the Division of Gynecologic Oncology at The Ohio State University College of Medicine, where I have been a faculty member since 2001. I was rated in the top 10 percent of physicians in the nation for patient satisfaction in 2016 and 2017.
I am the director of Medical Affairs at The James Cancer Hospital as well as the director of Gynecologic Cancer Research and the associate director of the Gynecologic Oncology Fellowship Program at Ohio State. After graduating from the University of Michigan, I attended Georgetown University School of Medicine in Washington, D.C., and completed my residency in obstetrics and gynecology at the University of Washington Medical Center in Seattle. I completed my fellowship in gynecologic oncology at Washington University in St. Louis.
My interests include investigation of value-based cancer care delivery, and have an active research program into the genetics and genomics of endometrial cancer. Additionally, our laboratory investigates signaling in ovarian cancer with a focus on early biomarkers of the disease. I am the secretary-treasurer of the Society of Gynecologic Oncology and hold leadership positions in NRG Oncology.
Education and Background
Georgetown University School of Medicine
University of Washington Medical Ctr
OB/GYN / Gynecological Oncology
Washington University Hospital
St. Louis, MO
- American Board of OB/GYN
- American Board of OB/GYN (Subspecialty: Gynecologic Oncology)
- Department of Obstetrics & Gynecology
- Division of Gynecologic Oncology
I see patients at
Stefanie Spielman Comprehensive Breast Center
1145 Olentangy River Road, Columbus, Ohio 43212
Consulting and Related Relationships
At The Ohio State University Wexner Medical Center, we support a faculty member’s research and consulting in collaboration with medical device, research and/or drug companies because a faculty member’s expertise can guide important advancements in the practice of medicine and improve patient care. In order to provide effective management of these relationships, the university requires annual disclosures from all faculty members with external interests related to their university responsibilities. As of 3/28/2017, Dr. Cohn has reported no financial relationships with medical device, research and/or drug companies.